13F Holdings
中文EN

GEVO Gevo, Inc.

Industrial Organic Chemicals · Nasdaq · SEC CIK 1392380 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY80.1%
TTM net income YoY-303.6%
TTM EPS YoY-261.9%
Revenue 3-yr CAGR153.5%
Net income 3-yr CAGR—

Margins

Gross margin51.2%
Operating margin-68.2%
Net margin-83.7%
FCF margin-14.2%
EBITDA margin-56.5%

Returns

ROE-47.5%
ROA-29.7%
ROIC (approx.)-24.5%
Asset turnover0.36x

Leverage & solvency

Liabilities / assets42.9%
Debt / equity0.56x
Current ratio2.04x
Interest coverage-7.05x

Cash quality & payout

Operating cash flow / net income-0.18x
Accruals ratio-35.0%
Payout ratio—
Capex / revenue28.8%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$160.58M$16.91M$17.20M$1.18M$533,000
Cost of revenue$85.24M$12.00M$11.99M$8.70M$7.69M
Gross profit$75.34M$4.91M$5.21M-$7.52M-$11.45M
R&D expense$4.55M$5.58M$6.64M$7.43M$6.78M
SG&A expense$51.20M$45.80M$42.63M$39.94M$25.49M
Operating income-$20.21M-$90.82M-$81.83M-$102.69M-$60.27M
Interest expense$17.56M$3.88M$2.16M$1.17M$251,000
Pretax income-$32.63M-$78.64M———
Net income-$33.84M-$78.64M-$66.22M-$98.01M-$59.20M
EBITDA$5.11M-$72.53M-$62.83M-$94.80M-$55.14M
EPS (basic)-0.14-0.34-0.28-0.44-0.30
EPS (diluted)-0.14-0.34-0.28-0.44-0.30
Weighted avg. shares (diluted)234.01M231.67M238.69M221.54M195.79M
Balance sheet
Cash & equivalents$81.16M$259.03M$375.60M$315.38M$136.03M
Short-term investments———$167.41M$275.34M
Receivables$8.39M$2.41M$2.62M$476,000$978,000
Inventory$19.08M$4.50M$3.81M$6.35M$2.75M
Current assets$143.40M$203.71M$386.38M$415.42M$348.54M
PP&E, net$353.58M$221.64M$211.56M$185.17M$137.74M
Goodwill$43.56M$3.74M———
Intangibles$95.00M$8.13M$6.52M$7.69M$8.94M
Total assets$718.93M$583.94M$650.32M$700.75M$645.38M
Current liabilities$78.58M$24.36M$91.43M$25.44M$29.09M
Short-term debt$0$21,000$68.10M$159,000$158,000
Long-term debt$164.75M$67.11M$21,000$67.38M$66.80M
Total debt$164.75M$67.13M$68.12M$67.54M$66.96M
Total liabilities$247.76M$94.45M$92.93M$95.27M$98.13M
Shareholders' equity$466.34M$489.49M$557.39M$605.48M$547.25M
Net debt$83.59M-$191.90M-$307.48M-$247.84M-$69.07M
Shares outstanding242.46M239.18M240.50M237.17M201.99M
Cash flow statement
Operating cash flow-$13.40M-$57.38M-$53.72M-$44.31M-$48.27M
Capital expenditure$30.11M$51.09M$54.45M$84.08M$56.77M
Free cash flow-$43.51M-$108.47M-$108.17M-$128.39M-$105.04M
Investing cash flow-$226.57M-$51.82M$114.13M$85.09M-$411.36M
Financing cash flow$97.88M-$7.36M-$189,000$138.56M$517.32M
Depreciation & amortization$25.32M$18.30M$19.01M$7.89M$5.13M
Stock-based compensation$9.21M$14.73M$17.09M$17.42M$9.87M
Share buybacks—$4.71M———

Free plan shows the latest 5 periods; Pro shows all 20 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.